Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Key facts

Sponsor

Case Western Reserve University

Principal Investigator

Amitabh Chak, MD

University Hospitals Cleveland Medical Center, CWRU, Cleveland, OH

Intervention

Balloon Capsule Device(device)

Enrollment

2000 enrolled

Eligibility

18 years · All sexes

Timeline

2005 – 2028

Study locations (10)

• Johns Hopkins Hospital, Baltimore, Maryland, United States
• Mayo Clinic, Rochester, Minnesota, United States
• Washington University School of Medicine, St Louis, Missouri, United States
• Columbia University Medical Center, New York, New York, United States
• University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
• University Hospitals of Cleveland, Cleveland, Ohio, United States
• Cleveland Clinic, Cleveland, Ohio, United States
• University of Pennsylvania, Philadelphia, Pennsylvania, United States
• VA Puget Sound Health Care System, Seattle, Washington, United States
• Fred Hutchinson Cancer Research Center, UWMC, Seattle, Washington, United States

Collaborators

University Hospitals Cleveland Medical Center · Washington University School of Medicine · Fred Hutchinson Cancer Center · University of Washington · Mercy Medical Center · Johns Hopkins University · Mayo Clinic · University of North Carolina, Chapel Hill · The Cleveland Clinic · University of Pennsylvania · Columbia University · VA Puget Sound Health Care System

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Adenocarcinoma of the cervix uteri

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07276360
  Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
  Uganda Cancer Institute
• RECRUITINGPHASE1NCT07454642
  AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
  Avacta Life Sciences Ltd
• RECRUITINGPHASE3NCT07061977
  Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
  National Cancer Institute (NCI)
• RECRUITINGNCT07359586
  Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
  Zhejiang University
• RECRUITINGPHASE1NCT07020117
  A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
  Aktis Oncology, Inc.
• RECRUITINGPHASE2NCT06654011
  IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT07153952
  RT for Adenocarcinoma/Adenosquamous Carcinoma
  Peking Union Medical College Hospital
• RECRUITINGNCT06733740
  Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
  Chinese PLA General Hospital

See all trials for Adenocarcinoma of the cervix uteri →